Amlodipine and Relpax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amlodipine (amlodipine besylate) and Relpax (eletriptan hydrobromide). Common drug interactions include blood alkaline phosphatase increased among females and back disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Amlodipine and Relpax. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,829 Amlodipine users. Check the latest studies of Amlodipine.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

On Jul, 19, 2026

93 people who take Amlodipine and Relpax together, and have interactions are studied.

Amlodipine and Relpax drug interactions.

What are the common drug interactions of Amlodipine and Relpax, by gender? *:

female:

Blood alkaline phosphatase increased
Blood cholesterol increased
Blood iron decreased
Blood potassium decreased
Confusional state
Sinusitis (inflammation of sinus)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Meningitis viral (viral inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Fatigue (feeling of tiredness)
Chronic kidney disease

male:

Back disorder
Drug ineffective
Back pain
Chest pain
Death
Decreased activity
Foot fracture
Haematoma (collection of blood outside the blood vessels)
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Hospitalisation

What are the common drug interactions of Amlodipine and Relpax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Application site burn
Application site erythema (redness of the skin at application site)
Application site pain
Application site reaction
Application site swelling
Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
Blood cholesterol increased
Blood iron decreased
Blood potassium decreased

40-49:

Aspartate aminotransferase increased
Back pain
Blood alkaline phosphatase increased
Chest pain
Decreased activity
Gamma-glutamyltransferase increased
Haematoma (collection of blood outside the blood vessels)
Pyrexia (fever)
Herpes oesophagitis (viral infection of the oesophagus caused by herpes simplex virus (hsv))
Lupus-like syndrome (a disease symptom matches with lupus an immune disease)

50-59:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Sinusitis (inflammation of sinus)
Meningitis viral (viral inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Chronic kidney disease
Renal failure (kidney dysfunction)
Tooth infection
Nephrogenic anaemia (anaemia due to kidney disease)
Procedural pain
Upper limb fracture
Weight fluctuation

60+:

Asthma
Blister infected (infection of small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Muscular weakness (muscle weakness)
Purulent discharge (discharge that contains pus)
Rotator cuff repair
Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
Scar
Ulcer
Wound secretion
Erythema (redness of the skin)

What are the existing conditions these people have? *

Pain: 20 people, 21.51%
Immunodeficiency Common Variable: 20 people, 21.51%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 17.20%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 14 people, 15.05%
Asthma: 11 people, 11.83%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 9.68%
High Blood Cholesterol: 8 people, 8.60%
Bipolar Disorder (mood disorder): 8 people, 8.60%
Multiple Allergies (allergy to multiple agents): 7 people, 7.53%
Depression: 6 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and Relpax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously